P W Wang

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients
    Po W Wang
    Stanford University School of Medicine, Stanford, CA, USA
    J Psychiatr Res 45:1128-32. 2011
  2. ncbi request reprint Overweight and obesity in bipolar disorders
    Po W Wang
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Room 2117, CA 94305 5723, USA
    J Psychiatr Res 40:762-4. 2006
  3. ncbi request reprint New anticonvulsant medication uses in bipolar disorder
    Po W Wang
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California, USA
    CNS Spectr 8:930-2, 941-7. 2003
  4. ncbi request reprint Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: a pilot study
    Po W Wang
    Stanford University School of Medicine, 401 Quarry Road, Suite 2117, Stanford, CA 94305 5723, United States
    J Psychiatr Res 42:451-7. 2008
  5. ncbi request reprint Gabapentin augmentation therapy in bipolar depression
    Po W Wang
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305 5723, USA
    Bipolar Disord 4:296-301. 2002
  6. doi request reprint Divalproex extended-release in acute bipolar II depression
    P W Wang
    Stanford University School of Medicine, Stanford, CA, USA
    J Affect Disord 124:170-3. 2010
  7. ncbi request reprint Clinical use of carbamazepine for bipolar disorders
    Po W Wang
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, CA, USA
    Expert Opin Pharmacother 6:2887-902. 2005
  8. doi request reprint Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions?
    T A Ketter
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA
    Acta Psychiatr Scand 123:175-89. 2011
  9. pmc Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder
    John O Brooks
    Palo Alto Veterans Affairs Health Care System, 3801 Miranda Avenue, Palo Alto, CA 94304, USA
    J Psychiatr Res 43:181-8. 2009
  10. ncbi request reprint Adjunctive aripiprazole in treatment-resistant bipolar depression
    Terence A Ketter
    Stanford University School of Medicine, Stanford, CA, USA
    Ann Clin Psychiatry 18:169-72. 2006

Detail Information

Publications26

  1. doi request reprint Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients
    Po W Wang
    Stanford University School of Medicine, Stanford, CA, USA
    J Psychiatr Res 45:1128-32. 2011
    ..To assess effectiveness and tolerability of open adjunctive ziprasidone for weight loss in obese/overweight patients with bipolar disorders (BD) in diverse mood states, taking weight gain-implicated psychotropic medications...
  2. ncbi request reprint Overweight and obesity in bipolar disorders
    Po W Wang
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Room 2117, CA 94305 5723, USA
    J Psychiatr Res 40:762-4. 2006
  3. ncbi request reprint New anticonvulsant medication uses in bipolar disorder
    Po W Wang
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California, USA
    CNS Spectr 8:930-2, 941-7. 2003
    ....
  4. ncbi request reprint Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: a pilot study
    Po W Wang
    Stanford University School of Medicine, 401 Quarry Road, Suite 2117, Stanford, CA 94305 5723, United States
    J Psychiatr Res 42:451-7. 2008
    ..To assess the effectiveness and tolerability of open adjunctive zonisamide in treatment of obesity in euthymic bipolar disorder (BD) patients...
  5. ncbi request reprint Gabapentin augmentation therapy in bipolar depression
    Po W Wang
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305 5723, USA
    Bipolar Disord 4:296-301. 2002
    ..Gabapentin (GBP) may be useful in bipolar disorders, including as adjunctive therapy for bipolar depression, although controlled studies suggest inefficacy as primary treatment for mania or treatment-resistant rapid cycling...
  6. doi request reprint Divalproex extended-release in acute bipolar II depression
    P W Wang
    Stanford University School of Medicine, Stanford, CA, USA
    J Affect Disord 124:170-3. 2010
    ..Divalproex extended-release (divalproex-ER) is effective in acute mania, and limited data suggest divalproex may have efficacy in acute bipolar depression...
  7. ncbi request reprint Clinical use of carbamazepine for bipolar disorders
    Po W Wang
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, CA, USA
    Expert Opin Pharmacother 6:2887-902. 2005
    ..This paper reviews the chemistry, pharmacodynamics and pharmacokinetics of CBZ, as well as reviews of the controlled trials of CBZ in acute bipolar mania, acute bipolar depression and bipolar maintenance treatment...
  8. doi request reprint Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions?
    T A Ketter
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA
    Acta Psychiatr Scand 123:175-89. 2011
    ..To compare bipolar treatment interventions, using number needed to treat (NNT) and number needed to harm (NNH)...
  9. pmc Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder
    John O Brooks
    Palo Alto Veterans Affairs Health Care System, 3801 Miranda Avenue, Palo Alto, CA 94304, USA
    J Psychiatr Res 43:181-8. 2009
    ..Prefrontal metabolic rates were inversely related to severity of depression. There was no evidence of regional hypermetabolism, perhaps because this phenomenon is less robust or more variable than prefrontal hypometabolism...
  10. ncbi request reprint Adjunctive aripiprazole in treatment-resistant bipolar depression
    Terence A Ketter
    Stanford University School of Medicine, Stanford, CA, USA
    Ann Clin Psychiatry 18:169-72. 2006
    ..There are limited management options for treatment-resistant depression in bipolar disorder (BD) patients...
  11. ncbi request reprint Preliminary evidence of differential relations between prefrontal cortex metabolism and sustained attention in depressed adults with bipolar disorder and healthy controls
    John O Brooks
    Palo Alto Veterans Affairs Health Care System, Palo Alto, CA 94304, USA
    Bipolar Disord 8:248-54. 2006
    ..To assess the relations between sustained attention as assessed by the Continuous Performance Test (CPT) and subgenual and dorsolateral prefrontal cortex metabolism in depressed patients with bipolar disorders and healthy controls...
  12. ncbi request reprint Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash
    Terence A Ketter
    Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305, USA
    J Clin Psychiatry 66:642-5. 2005
    ..To assess treatment-emergent rash incidence when using dermatology precautions (limited antigen exposure) and slower titration during lamotrigine initiation...
  13. ncbi request reprint Predictors of treatment response in bipolar disorders: evidence from clinical and brain imaging studies
    Terence A Ketter
    Department of Psychiatry and Behavioral Sciences, Bipolar Disorders Clinic, Stanford University School of Medicine, CA 94305 5273, USA
    J Clin Psychiatry 63:21-5. 2002
    ..Although it is not yet a clinical tool for bipolar disorders, brain imaging provides useful research data to understand the fundamental neurobiology of mood disorders and to more effectively target therapeutics...
  14. ncbi request reprint Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia?
    Terence A Ketter
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Bipolar Disorders Clinic, Room 2124, 401 Quarry Road, Stanford, CA 94305 5723, USA
    J Psychiatr Res 38:47-61. 2004
    ....
  15. ncbi request reprint The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disorders
    Terence A Ketter
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Calif 94305, USA
    J Clin Psychiatry 64:15-20. 2003
    ..We review the efficacy and tolerability of these diverse treatment options in bipolar disorders and explore possible relationships between clinical effects and GABAergic and antiglutamatergic mechanisms of action...
  16. pmc Dorsolateral and dorsomedial prefrontal gray matter density changes associated with bipolar depression
    John O Brooks
    Palo Alto Veterans Affairs Health Care System, Psychiatry Service, Palo Alto, CA, USA
    Psychiatry Res 172:200-4. 2009
    ..Moreover, our observed differences in gray matter density overlap metabolic areas of change and thus have implications for the conceptualization and treatment of affective disorders...
  17. doi request reprint Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients
    Rif S El-Mallakh
    Mood Disorders Research Program, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, 501 East Broadway, Medcenter One, Suite 340, Louisville, Kentucky 40202, United States
    J Affect Disord 111:372-7. 2008
    ..This phenomenon has only been described in case series format, and has not been prospectively validated...
  18. ncbi request reprint A new US-UK diagnostic project: mood elevation and depression in first-year undergraduates at Oxford and Stanford universities
    R A Chandler
    Stanford University School of Medicine, Stanford, CA, USA
    Acta Psychiatr Scand 118:81-5. 2008
    ..To investigate differences in prevalence of mood elevation, distress and depression among first-year undergraduates at Oxford and Stanford universities...
  19. ncbi request reprint Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders
    Suttiporn Janenawasin
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305 5723, USA
    Bipolar Disord 4:328-34. 2002
    ..To evaluate effects of olanzapine in diverse exacerbations of bipolar disorders...
  20. ncbi request reprint Pharmacokinetics of mood stabilizers and new anticonvulsants
    Po W Wang
    Department of Psychiatry and Behavioral Sciences, Bipolar Disorders Clinic, Stanford University School of Medicine, 401 Quarry Road, Room 2117, Stanford, CA 94305 5723, USA
    Psychopharmacol Bull 36:44-66. 2002
    ..Novel psychotropic effects of these drugs may also be demonstrated, based on their mechanisms of action and preliminary clinical data...
  21. ncbi request reprint Biology and recent brain imaging studies in affective psychoses
    P W Wang
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305 5723, USA
    Curr Psychiatry Rep 2:298-304. 2000
    ..We review brain imaging studies that have advanced our knowledge of psychosis in mood disorders, with respect to the continuum versus discrete entity hypotheses...
  22. ncbi request reprint Temperament-creativity relationships in mood disorder patients, healthy controls and highly creative individuals
    Connie M Strong
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Room 2124, Stanford, CA 94305 5723, USA
    J Affect Disord 100:41-8. 2007
    ..To investigate temperament-creativity relationships in euthymic bipolar (BP) and unipolar major depressive (MDD) patients, creative discipline controls (CC), and healthy controls (HC)...
  23. ncbi request reprint Enhanced creativity in bipolar disorder patients: a controlled study
    Claudia M Santosa
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, CA 94305 5723, USA
    J Affect Disord 100:31-9. 2007
    ..We assessed non-eminent creativity in euthymic bipolar (BP) and unipolar major depressive disorder (MDD) patients, creative discipline controls (CC), and healthy controls (HC)...
  24. ncbi request reprint The diverse roles of anticonvulsants in bipolar disorders
    Terence A Ketter
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305 5723, USA
    Ann Clin Psychiatry 15:95-108. 2003
    ..The categorical-mechanistic extension strives to address this issue, but requires systematic clinical investigation of more precise relationships between psychotropic profiles and discrete mechanisms of action to assess its merits...
  25. doi request reprint Toward interaction of affective and cognitive contributors to creativity in bipolar disorders: a controlled study
    Shefali Srivastava
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305 5723, USA
    J Affect Disord 125:27-34. 2010
    ..Enhanced creativity in bipolar disorder patients may be related to affective and cognitive phenomena...
  26. ncbi request reprint Temperamental commonalities and differences in euthymic mood disorder patients, creative controls, and healthy controls
    Cecylia Nowakowska
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Room 2350, Stanford, CA 94305 5723, USA
    J Affect Disord 85:207-15. 2005
    ..We explored temperamental commonalities and differences among euthymic bipolar (BP) and unipolar (MDD) mood disorder patients, creative discipline graduate student controls (CC), and healthy controls (HC)...